-
EMUC25 examines BRCA and PRS in hereditary GU cancers session
November 15, 2025What are the current updates regarding the significantly elevated prostate cancer (PCa) risk in individuals with BRCA mutations? What...
00 -
EMUC23 tackles current challenges of PSMA PET/CT in PCa
November 2, 2023Plenary Session 5 “Nuclear medicine in urology: Lessons learnt and new horizons” of the EAU Section of Urological Imaging (ESUI)...
-
EMUC23: GU cancer game-changers for 2023
September 14, 2023A collaborative approach to reviewing trials prevents tunnel vision Collaborative efforts are required to drive game-changing advancements in medical...
-
Diagnosing PCa – what’s the best option?
November 11, 2022The objective of the 14th European Multidisciplinary Congress on Urological Cancers is to work together to achieve the best...
-
PCa management essentials opens EMUC’s 10th year
November 9, 2018Throughout a decade, the European Multidisciplinary Congress on Urological Cancers (EMUC) has established its reputation as the leading platform...
